New York State Common Retirement Fund’s Codiak BioSciences, Inc. Common Stock CDAK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-132
Closed 3541
2022
Q2
$0 Sell
132
-10,800
-99% -$37.9K ﹤0.01% 3586
2022
Q1
$69K Hold
10,932
﹤0.01% 3100
2021
Q4
$122K Sell
10,932
-17
-0.2% -$236 ﹤0.01% 3028
2021
Q3
$179K Sell
10,949
-2,602
-19% -$46.5K ﹤0.01% 2948
2021
Q2
$251K Buy
13,551
+9,551
+239% +$183K ﹤0.01% 2947
2021
Q1
$60K Hold
4,000
﹤0.01% 3180
2020
Q4
$129K Buy
+4,000
New +$52.9K ﹤0.01% 2919

Other funds holding CDAK

New York State Common Retirement Fund's CDAK Position: Q3 2022 in Review

New York State Common Retirement Fund sold out of Codiak BioSciences, Inc. Common Stock (CDAK) in Q3 2022, closing a stake of 132 shares.

New York State Common Retirement Fund first reported a position in CDAK in Q4 2020 and held it in 7 quarters. The position peaked at $251K in Q2 2021. 48 funds tracked by Wall St. Rank hold CDAK as of Q3 2022.

  • New York State Common Retirement Fund reported no remaining Codiak BioSciences, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • New York State Common Retirement Fund sold 132 Codiak BioSciences, Inc. Common Stock shares in Q3 2022.
  • New York State Common Retirement Fund first reported a position in Codiak BioSciences, Inc. Common Stock in Q4 2020 and held it in 7 quarters.
  • New York State Common Retirement Fund's Codiak BioSciences, Inc. Common Stock position peaked at $251K in Q2 2021.
  • 48 funds tracked by Wall St. Rank held Codiak BioSciences, Inc. Common Stock as of Q3 2022.

Based on New York State Common Retirement Fund's 13F filing for Q3 2022, filed 8 Nov 2022.